OSTEOARTROZ I METABOLIChESKIY SINDROM


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article considers the pathogenetic relationship between two common diseases - osteoarthrosis (OA) and the metabolic syndrome (MS). The data on the role of inflammatory mediators, including adipokines, in the development of articular cartilage damage are presented. The presence of MS and its individual components is a risk factor for OA of various joints, especially in women and Asians, and the frequency of MS is higher in patients with OA. This correlation promotes search for common therapeutic approaches for these diseases.

Full Text

Restricted Access

References

  1. Ревматология. Клинические рекомендации / Под ред. Е.Л. Насонова. М., 2005. 288 с.
  2. Рациональная фармакотерапия ревматических заболеваний: руководство для практикующих врачей / Под ред. В.А. Насоновой, Е.Л. Насонова. М., 2003. Т. 3. Гл. 12.
  3. Osteoarthritis: clinical and experimental aspects. Ed. by Reginster J.Y., Pelletier J.-P., Martel-Pellitier J., Henrotin Y. Berlin: Springer-Verlag, 1999.
  4. Dingle J.T., Parker M. NSAID Stimulation of Human Cartilage Matrix Synthesis. Clin Drug Invest 1997; 14(5): 353-62.
  5. Huskisson E.K. Clinical aspects of chondroprotection. Sem Arthr Rheum 1990; 19: 30-2.
  6. Коваленко В.Н., Борткевич О.П. Остеоартроз. Практическое руководство. К., 2003. 448 с.
  7. Manninen P., Riihimaki H., Feliovaara M. Overweight, gender and knee osteoarthritis. Int J Obes Relat Metab Disord 1996; 6: 595-97.
  8. Sellam J., Herrero-Beaumont G., Berenbaum F. Osteoarthritis: pathogenesis, clinical aspects and diagnosis. EULAR Compendium on Rheumatic Disease. BMJ Publishing Group, 2009: 451.
  9. Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: 745-51.
  10. Lago F., Dieguez C., Gomez-Reino J., et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007; 3: 716-24.
  11. Dumond H., Presle N., Terlain B., et al. Evidence for a key role of leptin in osteoarthritis. Arthr Rheum 2003; 48: 3118-29.
  12. Gualillo O. Editorial: Further evidence for leptin involvement in cartilage homeostasis. Osteoarthritis Cartilage 2007; 15: 857-60.
  13. Grotle M., Hagen K.B., Natvig B., et al. Obesity and osteoarthritis in knee hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoscelet Disord 2008; 9: 132.
  14. Kraus V.B. Do biochemical markers have a role in osteoarthritis diagnosis and treatment ? Best Pract Res Clin Rheumatol 2006; 20: 69-80.
  15. Masuko K., Murata M., Suematsu N., et al. A methabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumarol 2009; 27(2): 347-53.
  16. Национальные клинические рекомендации "Диагностика и лечение метаболического синдрома" (второй пересмотр) // Кардиоваскулярная терапия и профилактика 2009, № 8 (6). Прил. 2.
  17. Resnick H.E., Hones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003; 26: 861-67.
  18. Shen W., Punyanitya M., Wang Z.M., et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 2004; 97: 2333-38.
  19. World Health Organisation. Definition, diagnoses ahd classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: The Organisation, 1999.
  20. Gandhi R., Dhotar H., Tsvetkov D., et al. The relation between body mass index and waist-hip ratio in knee osteoarthritis. Can J Surg 2010; 53(3): 151.
  21. Spector T.D., Champion G.C. Generalized osteoarthritis is a hormonally mediated disease. Ann Rheum Dis 1989; 48: 356-61.
  22. Puenpatom R.A., Victor T.W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009; 212(6): 9-20.
  23. Gandhi R., Razak F., Tso P., et al. Asian ethnicity and the prevalence of metabolic syndrome in the osteoarthritic total knee arthroplasty population. J Arthroplasty 2010; 25(3): 416-19.
  24. Inoue R., Ishibashi Y., Tsuada E., et al. Medical problems and risk factors of metabolic syndrome among radiographic knee osteoarthritis patients in the Japanese general population. J Orthop Sci 2011; 16(6): 704-09.
  25. Rojaz-Rodriguez J., Escobar-Linares L., Garcia-Carrasco M., et al. The relationship between the metabolic syndrome and energy-utilisation deficit in the pathogenesis of obesity-induced osteoarthritis. Med Hypotheses 2007; 69: 860-68.
  26. Katz J.D., Aqrawal S., Velazquez M. Getting to the heart of the matter: osteoarthritis takes its place as a part of the metabolic syndrome. Curr Opin Rheumatol 2010; 22(5): 512-19.
  27. Кратнов А.Е., Курилева К.В., Кратнов А.А. Взаимосвязь между первичным остеоартрозом и метаболическим синдромом в соответствии с данными артроскопии и цитохимическими исследованиями // Клин. медицина 2006. № 84(6). С. 42-6.
  28. Хорошина И.Е. Определение С-пептида, сывороточного инсулина и характеристика инсулинорезистентности у больных остеоартрозом // Клин. лаб. диагностика 2008, № 7. С. 18-22.
  29. Endström G., Gerhardsson de Verdier M., Kollof J., et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009; 17(2): 168-73.
  30. Хорошина И.Е., Багирова Г.Г. Метаболический синдром и течение остеоартроза // Тер. архив 2007. № 79(10). С. 13-20.
  31. Leite A.A., Costa A.J.G., Arrunda Matheos de Lima B., et al. Comorbidities in patient with osteoarthritis: frequency and impact on pain and physical function. Rev Bras Rhuematol 2011; 51(2): 113-23.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies